Thank you! Your request has been received.
A member of our team will reach out to you shortly,
Oops! Something went wrong while submitting the form.
+
Simulate, validate, and accelerate decisions with KnolScapes’ living knowledge platform.
Knolens KnolScapes streamlines drug development and commercialization strategies by delivering a continuously updating, real-time intelligence platform across key functions.
1. Therapy landscapes and competitive positioning
2. Disease overviews with epidemiology and burden insights
3. HEOR and HTA analyses for market access strategy
4. Clinical study designs optimized through scenario planning
5. Biomarker discovery and patient outcome tracking for 100+ indications
Whether you need off-the-shelf analytics or customized modules tailored to your therapeutic focus, KnolScapes delivers:
✔️ 10+ Specialized Modules covering the full drug development value chain
✔️ 50+ Deep-Dive Analysis Panels for real-time insights
✔️ Continuous Auto-Updates to reflect the latest research, trials, and approvals
✔️ Customizable Frameworks to adapt analyses by function, region, or project
Accelerate approvals, optimize strategies, and deliver high-impact insights — all through a living, decision-ready intelligence platform.
Access ready-to-use modules covering key life sciences functions for faster insights.
Stay current with data that refreshes in real time — no manual updates needed.
Customize the platform with modules tailored to your disease area or functional needs.
Get structured summaries across disease burden, treatment landscape, and clinical rationale.
Explore biomarkers by target, tumor type, and measurement method — all in one view.
Compare outcomes by target, trial size, MoA, and treatment line to assess real-world impact.
Generate bespoke analysis across internal and relevant public data sources.
Assess market positioning, HTA feedback, and price/value metrics to shape access strategies.
Knolens connects pricing, regulatory, and clinical data for a context-rich view of market access dynamics.
Refresh or re-run analysis instantly to reflect the latest decisions or data changes — no rework needed.
Understand what influences regulatory and payer decisions across global markets.
Compare outcomes by drug class, study design, and treatment sequence to support HEOR and value narratives.
Prioritize targets and mechanisms of action based on clinical differentiation and market acceptance benchmarks.
Evaluate asset positioning against payer thresholds and QALY-based value frameworks.
Whether mapping therapy landscapes, tracking disease evolution, assessing biomarker performance, or evaluating patient outcomes, KnolScapes delivers the real-tim¯e precision, depth, and scientific rigor required to drive smarter, faster decisions across the drug development lifecycle.
